CBAY - CymaBay Therapeutics (CBAY) CEO Sujal Shah on Q3 2020 Results - Earnings Call Transcript
CymaBay Therapeutics, Inc. (CBAY) Q3 2020 Earnings Conference Call November 05, 2020 04:30 PM EST Company Participants Dan Menold - VP of Finance Sujal Shah - CEO Chuck McWherter - CSO Klara Dickinson - CRO Conference Call Participants Yasmeen Rahimi - Piper Sandler Steve Seedhouse - Raymond James Jay Olson - Oppenheimer Mayank Mamtani - B. Riley Patrick Dolezal - LifeSci Capital Thomas Smith - SVB Leerink Derek Archila - Stifel Presentation Operator Good day, ladies and gentlemen, and welcome to CymaBay's third-quarter 2020 financial results and business update conference call. [Operator instructions] Please be advised that the call will be recorded at the company's request. It is also being webcast live on the investors section at the CymaBay website at www.cymabay.com. Now I'd like to turn the call over to Mr. Dan Menold, vice president of finance at CymaBay. Mr. Menold, please proceed. Dan Menold Thank you, operator, and
For further details see:
CymaBay Therapeutics (CBAY) CEO Sujal Shah on Q3 2020 Results - Earnings Call Transcript